Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study - Concepedia

Concepedia

Publication | Closed Access

Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study

36

Citations

21

References

2010

Year

Craig LaForce, Joseph Aumann, L. de Teresa Parreño, Amir Iqbal, David Young, Roger Owen, Mark Higgins, Benjamin Krämer

Pulmonary Pharmacology & Therapeutics

Advanced Lung DiseaseDaily IndacaterolPulmonary PharmacologyPharmacotherapyCrossover StudyMedicinePulmonary Disease24-Hour Efficacy

References

	Year	Citations

Page 1